Clinical trial
A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer…
NCT00263211 · Washington University School of Medicine, Other · Terminated
Key facts
| NCT number | NCT00263211 |
|---|---|
| Title | A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients |
| Official title | The Impact Of Platelet Function Inhibition On Circulating Cancer Cells In Metastatic Breast Cancer Patients |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | Barnes-Jewish Hospital |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | Plavix, Aspirin |
| Enrollment | 48 |
| Start date | Jan 1, 2006 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Dec 7, 2005 |
| Last update posted | Mar 15, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: